US 11760764
Methods and compositions for targeting PD-L1
granted A61PA61P31/20A61P35/00
Quick answer
US patent 11760764 (Methods and compositions for targeting PD-L1) held by Aligos Therapeutics, Inc. expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P31/20, A61P35/00